Measuring peptide translocation into large unilamellar vesicles.
There is an active interest in peptides that readily cross cell membranes without the assistance of cell membrane receptors(1).  Many of these are referred to as cell-penetrating peptides, which are frequently noted for their potential as drug delivery vectors(1-3). Moreover, there is increasing interest in antimicrobial peptides that operate via non-membrane lytic mechanisms(4,5), particularly those that cross bacterial membranes without causing cell lysis and kill cells by interfering with intracellular processes(6,7).  In fact, authors have increasingly pointed out the relationship between cell-penetrating and antimicrobial peptides(1,8).  A firm understanding of the process of membrane translocation and the relationship between peptide structure and its ability to translocate requires effective, reproducible assays for translocation. Several groups have proposed methods to measure translocation into large unilamellar lipid vesicles (LUVs)(9-13).  LUVs serve as useful models for bacterial and eukaryotic cell membranes and are frequently used in peptide fluorescent studies(14,15). Here, we describe our application of the method first developed by Matsuzaki and co-workers to consider antimicrobial peptides, such as magainin and buforin II(16,17).  In addition to providing our protocol for this method, we also present a straightforward approach to data analysis that quantifies translocation ability using this assay.  The advantages of this translocation assay compared to others are that it has the potential to provide information about the rate of membrane translocation and does not require the addition of a fluorescent label, which can alter peptide properties(18), to tryptophan-containing peptides.  Briefly, translocation ability into lipid vesicles is measured as a function of the Foster Resonance Energy Transfer (FRET) between native tryptophan residues and dansyl phosphatidylethanolamine when proteins are associated with the external LUV membrane (Figure 1).  Cell-penetrating peptides are cleaved as they encounter uninhibited trypsin encapsulated with the LUVs, leading to disassociation from the LUV membrane and a drop in FRET signal.  The drop in FRET signal observed for a translocating peptide is significantly greater than that observed for the same peptide when the LUVs contain both trypsin and trypsin inhibitor, or when a peptide that does not spontaneously cross lipid membranes is exposed to trypsin-containing LUVs.  This change in fluorescence provides a direct quantification of peptide translocation over time.
Department of Chemistry, Wellesley College, USA.
Sara A
SA
Spinella
Rachel B
RB
Nelson
Donald E
DE
Elmore
D003619:Dansyl Compounds / Q000737:chemistry; D031541:Fluorescence Resonance Energy Transfer / Q000379:methods*; D010455:Peptides / Q000737:chemistry* / Q000378:metabolism; D010713:Phosphatidylcholines / Q000737:chemistry / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000737:chemistry; D010715:Phosphatidylglycerols / Q000737:chemistry / Q000378:metabolism; D014357:Trypsin / Q000737:chemistry; D053835:Unilamellar Liposomes / Q000737:chemistry* / Q000378:metabolism
D003619:Dansyl Compounds; D010455:Peptides; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010715:Phosphatidylglycerols; D053835:Unilamellar Liposomes; C024284:dansyl phosphatidylethanolamine; C060037:1-palmitoyl-2-oleoylglycero-3-phosphoglycerol; D014357:Trypsin; C028694:1-palmitoyl-2-oleoylphosphatidylcholine